Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Analytical Community Rewards Postnova System with 2012 Innovations Award

Published: Monday, December 17, 2012
Last Updated: Monday, December 17, 2012
Bookmark and Share
The new CF2000 Series for high-resolution separation and fractionation of nanoparticles has won the prestigious GIT Innovations Award 2012 in the category ‘Analytical Instrumentation and Software’.

The Postnova team are the inventors of the Field-Flow Fractionation (FFF) technique, and developed the CF2000 to be the first Centrifugal FFF system for routine use.

Dr Thorsten Klein, Founder and CEO, Postnova, said: “It is a great honour to receive this award. To be acknowledged by scientists working at the bench is particularly important for us as it shows that our innovative products are recognized as powerful practical tools for daily analysis, exactly what we designed them to be. I would like to thank the publishers at G.I.T. Verlag for sponsoring the award, the independent jury who placed the CF2000 on the shortlist and, most of all, everyone who took the time to vote for us online, at Analytica, and at Achema.”

The CF2000 is modular, allowing for a range of different detectors: Multi-Angle Light Scattering (MALS) , Dynamic Light Scattering (DLS) and Refractive Index (RI), for example, to be integrated. Whatever the configuration, everything from autosampler to detector is fully controlled by the NovaFFF software platform.
 
Importantly, by using a centrifugal field as the controlling force for the separation, particles are separated by Dynamic Diffusion on the basis of size and density. This novel approach allows discrimination of materials that have the same particle size but different densities.

The CF2000 has a wide operation range and is able to separate smaller species, such as proteins and polymers, from larger particles in one run with high resolution. The system is ideal for nanoparticles and works up into the microparticle size range too. No special sample treatment is necessary, allowing challenging biopharmaceutical, food-cosmetics, nanomaterial and environmental samples to be characterized.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!